Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome

Andrea Beaton1, Twalib Aliku2, Alyssa Dewyer2

  • 1Children's National Health System, Washington DC (A.B., A.D., M.J., J.J., R.M., A.S., C.S.). Gulu University, Uganda (T.A.). Case Western Reserve University, Cleveland, OH (C.T.L.). Uganda Heart Institute, Kampala (S.L., J.N., E.O., E.T., P.L.). INSERM U970 (French National Institute of Health and Medical Research), Paris-Cardiovascular Research Center PARCC, France (M.M.). Joint Clinical Research Centers, Kampala, Uganda (G.M.). abeaton@childrennational.org.

Circulation
|October 4, 2017
PubMed

Insights

Latent rheumatic heart disease (RHD) in children shows variable outcomes, with moderate-to-severe cases having poor prognosis. Early diagnosis via echocardiography and risk factor identification are crucial for managing RHD progression.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Rheumatic heart disease (RHD) is a significant concern in pediatric populations.
  • Screening echocardiography offers potential for early RHD diagnosis.
  • Understanding RHD progression and penicillin prophylaxis efficacy is vital.

Purpose of the Study:

  • To report longitudinal outcomes of children with latent RHD.
  • To identify risk factors associated with unfavorable RHD outcomes.
  • To evaluate the impact of penicillin prophylaxis on RHD progression.

Main Methods:

  • Prospective natural history study of children in the Ugandan RHD registry.
  • Expert re-review of echocardiograms using 2012 World Heart Federation criteria.
  • Statistical analyses including logistic regression, Kaplan-Meier, and Cox proportional hazards models; propensity matching for penicillin effect evaluation.

Main Results:

  • 227 children with latent RHD confirmed: 164 borderline, 63 definite (42 mild, 21 moderate/severe).
  • Moderate-to-severe RHD cases showed 47.6% progression; mild/borderline cases had lower progression but significant improvement rates.
  • Advanced disease, younger age, and mitral valve morphology were risk factors for unfavorable outcomes in mild/borderline RHD.

Conclusions:

  • Latent RHD is heterogeneous with diverse outcomes; moderate-to-severe RHD carries poor prognosis.
  • Borderline and mild definite RHD cases face substantial progression risk.
  • Further research, including randomized trials, is needed to clarify penicillin's role in latent RHD trajectory.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
603
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
730
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
401
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
364
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
336
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
850